T1Type1Cure
A diabetes education and community support setting.
Carolyn Rafieymehr / Wikimedia Commons / Public domain
Clinical Trials/July 12, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) — RECRUITING. Interventions: Omnipod 5. Locations: Angers, France | Besançon, France | Bobigny, France. The purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life,...Source
  • Regulation of Brain Glucose Metabolism in Type 1 Diabetes — RECRUITING, EARLY_PHASE1. Interventions: Dichloroacetate. Locations: New Haven, Connecticut, United States. This is a prospective randomized placebo-controlled double-blind crossover pilot study determining the effect o...Source
  • A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity — RECRUITING, PHASE1. Interventions: NNC0497-0040, Placebo. Locations: Neuss, Germany. The purpose of this clinical study is to find out if NNC0497-0040 is safe, tolerable and effective for healthy people living with norm...Source
  • ROME GS System Study — RECRUITING, NA. Interventions: Continuous Glucose Monitoring System. Locations: Escondido, California, United States | Walnut Creek, California, United States | San Antonio, Texas, United States. The purpose of this cli...Source
  • Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM — RECRUITING, NA. Interventions: CareSens Air 3 primary insertion, CareSens Air 3 secondary insertion. Locations: Escondido, California, United States | Walnut Creek, California, United States | Atlanta, Georgia, United S...Source
  • Effect of Inulin Supplementation on Glycaemic Control and Immunological Parameters in Type 1 Diabetes (2024) — RECRUITING, NA. Interventions: Inulin (prebiotic, fermentable fiber), Placebo. Locations: Amsterdam, Netherlands | Amsterdam, Netherlands. The goal is to establish the effect of oral inulin supplementation on continuous...Source
  • Technology-Enabled Collaborative Care for Young Adults With Type 1 Diabetes and Diabetes Distress: A Feasibility Trial — RECRUITING, NA. Interventions: TECC-T1D3 Program, Education Intervention. Locations: Toronto, Ontario, Canada. The goal of the study is to evaluate the acceptability and feasibility of a co-designed, Technology-Enabled...Source
  • Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes — RECRUITING, PHASE3. Interventions: Aspirin tablet, Semaglutide, Sotagliflozin. Locations: Copenhagen, Denmark | Herlev, Denmark. A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.